1
|
Osama MA, Chatterjee P, Singh S, Pandey A, Mohta A. Myxoid liposarcoma diagnosed on fine needle aspiration cytology: There is more to it than meets the eye. J Cancer Res Ther 2024:01363817-990000000-00095. [PMID: 39016314 DOI: 10.4103/jcrt.jcrt_419_24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2024] [Accepted: 06/14/2024] [Indexed: 07/18/2024]
Abstract
ABSTRACT Liposarcoma is a rare mesenchymal neoplasm commonly involving deep soft tissues and the retroperitoneum. Among the various types of liposarcoma, myxoid liposarcoma is the most frequently encountered in adolescents and young adults, with a predilection for lower extremities. Fine needle aspiration allows easy assessment and rapid on-site evaluation for distinguishing benign from malignant lipomatous lesions. Here, we present a case of myxoid liposarcoma in the calf region of a 19-year-old boy, diagnosed via fine needle aspiration cytology, and subsequently confirmed by histopathological examination after surgical resection. The intention behind this case report is to highlight the cytological features of myxoid liposarcoma and to improve understanding of this tumor entity, aiming to prevent misdiagnosis by inexperienced pathologists when evaluating cytology specimens.
Collapse
Affiliation(s)
- Md Ali Osama
- Department of Pathology, Lady Hardinge Medical College, New Delhi, India
| | - Priti Chatterjee
- Department of Pathology, Lady Hardinge Medical College, New Delhi, India
| | - Smita Singh
- Department of Pathology, Lady Hardinge Medical College, New Delhi, India
| | - Ankita Pandey
- Department of Pathology, Lady Hardinge Medical College, New Delhi, India
| | - Anup Mohta
- Departments of Surgery, Lady Hardinge Medical College, New Delhi, India
| |
Collapse
|
2
|
Aoki J, Yamamoto Y, Horikawa A, Doiuchi T, Hino A, Kojima D, Kurihara H, Washimi K, Katoh H, Hiruma T. Fluorodeoxyglucose positron emission tomography (FDG/PET) shows the effect of carbon-ion radiotherapy (CIRT); with pathologic confirmation. Radiol Case Rep 2023; 18:1793-1795. [PMID: 36915607 PMCID: PMC10006709 DOI: 10.1016/j.radcr.2023.02.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2022] [Revised: 01/30/2023] [Accepted: 02/01/2023] [Indexed: 03/06/2023] Open
Abstract
Response evaluation of carbon-ion radiotherapy poses a diagnostic challenge. Due to its functional aspects, fluorodeoxyglucose positron emission tomography (FDG/PET) has a role in the diagnosis of photon radiation therapy. In addition, several studies suggested that FDG/PET may be useful to select the optimal site for performing a diagnostic biopsy. Here, we report a 73-year-old female in which FDG/PET was effective in determining the recurrence of liposarcoma and the therapeutic effect. Based on the results of FDG/PET, we could make a pathologic definitive diagnosis and selectively performing carbon-ion radiotherapy for active tumors.
Collapse
Affiliation(s)
- Jun Aoki
- Department of Radiology and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan
| | - Yayoi Yamamoto
- Department of Radiology and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan
| | - Ayumi Horikawa
- Department of Radiology and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan
| | - Tsunehiro Doiuchi
- Department of Radiology and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan
| | - Ayako Hino
- Department of Radiology and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan
| | - Daichi Kojima
- Department of Radiology and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan
| | - Hiroaki Kurihara
- Department of Radiology and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan
| | - Kota Washimi
- Department of Pathology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan
| | - Hiroyuki Katoh
- Department of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan
| | - Toru Hiruma
- Department of Musculoskeletal Tumor Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan
| |
Collapse
|
3
|
Zhang Y, Li X, Zhang Y, Ye Y, Pan X, Hu T, Chen W, Chai H, Wang X, Yang Y. Carbon ion radiotherapy for recurrent ameloblastoma: A case report. SAGE Open Med Case Rep 2022; 10:2050313X221082416. [PMID: 35355852 PMCID: PMC8958705 DOI: 10.1177/2050313x221082416] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2021] [Accepted: 02/06/2022] [Indexed: 11/30/2022] Open
Abstract
Ameloblastoma is a kind of benign, odontogenic tumor of epithelial origin, and surgery is mainstay treatment method; however, recurrence is common, and usually the treatment for recurrence is still surgery. We report on a patient of recurrent ameloblastoma treated with carbon ion radiation therapy and achieved a good efficacy. A 25-year-old female with relapse of an ameloblastoma was referred to the Wuwei Heavy Ion Center for carbon ion therapy. She had been initially diagnosed with ameloblastoma 8 years ago and underwent operation of right mandible ameloblastoma. After she transferred to our center, she accepted a dose of 60 GyE carbon ion radiation therapy, and the efficacy is good. Carbon ion radiation therapy can be an effective treatment option for ameloblastoma.
Collapse
Affiliation(s)
- Yihe Zhang
- Heavy Ion Radiotherapy of Wuwei Tumor Hospital, Wuwei, China
| | | | | | - Yancheng Ye
- Heavy Ion Radiotherapy of Wuwei Tumor Hospital, Wuwei, China
| | - Xin Pan
- Heavy Ion Radiotherapy of Wuwei Tumor Hospital, Wuwei, China
| | - Tingchao Hu
- Heavy Ion Radiotherapy of Wuwei Tumor Hospital, Wuwei, China
| | - Weizuo Chen
- Heavy Ion Radiotherapy of Wuwei Tumor Hospital, Wuwei, China
| | - Hongyu Chai
- Heavy Ion Radiotherapy of Wuwei Tumor Hospital, Wuwei, China
| | - Xin Wang
- Heavy Ion Radiotherapy of Wuwei Tumor Hospital, Wuwei, China
| | - Yuling Yang
- Heavy Ion Radiotherapy of Wuwei Tumor Hospital, Wuwei, China
| |
Collapse
|
4
|
Li X, Zhang Y, Zhang Y, Ye Y, Qi Y, Hu T, Pan X. Carbon ion radiotherapy with complete tumor regression for primary malignant melanoma of female urethra orifice: a case report. J Int Med Res 2022; 50:3000605211072795. [PMID: 35000479 PMCID: PMC8743953 DOI: 10.1177/03000605211072795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2021] [Accepted: 12/20/2021] [Indexed: 11/16/2022] Open
Abstract
Primary malignant melanoma of the female urethra (PMMFU) is extremely rare, accounting for 0.2% of all melanomas, and fewer than 200 cases have been reported worldwide. Because of the small number of clinical cases and unclear biological characteristics, there is no uniform and standard treatment protocol. We herein describe the treatment of PMMFU using carbon ion radiotherapy. The radiotherapy was delivered at 60.8 Gy (RBE) in 16 fractions, once daily, five times per week. The patient achieved complete tumor disappearance within 1 year after carbon ion radiotherapy and remained disease-free thereafter. She developed acute grade 1 radiation dermatitis and urethritis, which resolved quickly; no other toxic effects were observed. At the time of this writing, her survival duration was 33 months. This case demonstrates that carbon ion radiotherapy may be a good option for primary genitourinary mucosal malignancies.
Collapse
Affiliation(s)
| | | | - Yanshan Zhang
- Heavy Ion Center of Wuwei Cancer Hospital, Wuwei, Gansu, China
| | - Yancheng Ye
- Heavy Ion Center of Wuwei Cancer Hospital, Wuwei, Gansu, China
| | - Ying Qi
- Heavy Ion Center of Wuwei Cancer Hospital, Wuwei, Gansu, China
| | - Tingchao Hu
- Heavy Ion Center of Wuwei Cancer Hospital, Wuwei, Gansu, China
| | - Xin Pan
- Heavy Ion Center of Wuwei Cancer Hospital, Wuwei, Gansu, China
| |
Collapse
|